Results 101 to 110 of about 6,416 (177)

Triosephosphate isomerase from Fasciola hepatica: high-resolution crystal structure as a drug target. [PDF]

Acta Crystallogr F Struct Biol Commun
Kontellas G, Studholme DJ, van der Giezen M, Timson DJ, Littlechild JA, Isupov MN.   +5 more
europepmc   +1 more source

Pilot study on the population genetics structure of <i>Fasciola hepatica</i> from seven provinces of South Africa. [PDF]

Front Vet Sci
Nukeri S, Malatji MP, Mnisi CM, Chaisi M, Mukaratirwa S.   +4 more
europepmc   +1 more source

Harnessing mRNA technology against <i>Fasciola hepatica</i>: Immunological insights from a fatty acid binding protein vaccine. [PDF]

Front Immunol
Sánchez-Montejo J, Teodosio C, Strilets T, López-Abán J, Manzano-Román R, Pozo J, Martin S, Silos L, Trujillo I, García-Blanco MA, Vicente B, Muro A.   +11 more
europepmc   +1 more source

Protection of mice against septic shock induced by lethal intraperitoneal dose of LPS by a recombinant <i>Fasciola hepatica</i> fatty acid binding protein. [PDF]

Microbiol Spectr
Armina-Rodriguez A, Dorta-Estremera SM, Mendez LB, Espino AM.   +3 more
europepmc   +1 more source

Optimization and workflow of in vitro culture of adult Fasciola hepatica. [PDF]

Rev Bras Parasitol Vet
Burga-Cisterna C, Málaga E, Serrano-Martínez E, Livia-Córdova G, Antezana R, Luna AC, Pajuelo M.   +6 more
europepmc   +1 more source

Structural Insights and Calcium-Switching Mechanism of <i>Fasciola hepatica</i> Calcium-Binding Protein FhCaBP4. [PDF]

Int J Mol Sci
Shin B, Park S, Park I, Shin H, Bang K, Kim S, Hwang KY.   +6 more
europepmc   +1 more source

Fasciola hepatica-Derived Proteins Shield the Heart From Type 2 Myocardial Infarction in Rats by Modulating Oxidative Stress and Inflammatory Imbalance: Insights Relevant to the Hygiene Hypothesis. [PDF]

Oxid Med Cell Longev
Ahmadi-Beni M, Mokhtarian K, Mobini GR, Najafi-Chaleshtori S, Salehi-Vanani N, Anjomshoa M, Houshmand F.   +6 more
europepmc   +1 more source

Challenges in applying W.A.A.V.P. criteria to diagnosing triclabendazole resistance in Fasciola hepatica, an example from the Southern Tablelands of New South Wales, Australia. [PDF]

Int J Parasitol Drugs Drug Resist
Uthayakumar C, DeCristi HM, Francis EK, Willoughby RA, Taylor S, Davies Calvani NE.   +5 more
europepmc   +1 more source

Response of the tegument of <i>Fasciola hepatica</i> to infection and immunization sera <i>in vitro</i>. [PDF]

Parasitology
Bennett CE, Bennett APS, Hanna REB, Robinson MW.   +3 more
europepmc   +1 more source

Independent origins and non-parallel selection signatures of triclabendazole resistance in Fasciola hepatica. [PDF]

Nat Commun
Choi YJ, Rosa BA, Fernandez-Baca MV, Ore RA, Martin J, Ortiz P, Hoban C, Cabada MM, Mitreva M.   +8 more
europepmc   +1 more source